Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSXV:
$KHRN.V) (CSE: $XCX.C) (CSE: $CNNA.C) (TSX: $VFF.TO) (NYSE: $ACB)
Delta, Kelowna, BC –September 4, 2019 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/09041KHRN-XCX-CNNA-VFF-ACB.asp
Today's podcast overview/transcript
Good afternoon and welcome to another episode of
Investorideas.com "Potcast" featuring cannabis news, stocks to watch
as well as insights from thought leaders and experts.
In
today’s podcast we look at a few early announcements.
Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) announced today that it has commenced construction of a
9,800 m2 (105,486 sq.ft) cultivation and processing facility in Juan
Lacaze, Uruguay. With a production capacity of 17 tons per year, the Company's
investment in this state-of-the-art facility represents a significant increase
in Khiron's total production capacity, strengthening its ability to export and
supply cannabis to key international markets, including Brazil and Europe.
Construction is underway and is scheduled for completion in mid Q3 2020
Located
strategically within an hour's distance from the international airport and
port, the facility will include 8,000 m2 of covered area for
cultivation, where controlled conditions of irrigation, temperature, humidity
and light will be implemented for optimum crop development. An 1,800 m2
processing plant will also be built on site for drying and processing crops,
with pharmaceutical-grade design standards in place to ensure quality control
across the analysis process. The cultivation area and processing plant will be
built to meet the requirements of Good Agricultural Practices (GAP) and Good
Manufacturing Practices (GMP), respectively, in keeping with Khiron's continued
expertise and core commitment to regulatory and operational compliance.
Alvaro
Torres, CEO and Director of Khiron Life Sciences, commented: "With
construction of our facility in Juan Lacaze, we are actively executing on our
strategy to build a dominant position in Latin America and further expand our
global reach. Through its inclusion in the Mercosur trade bloc, Uruguay is
poised to become a key source to supply the global medical cannabis industry.
Our production in the country will target domestic use in Uruguay and export
across one of the world's largest trading blocs, beginning with export to
Brazil, home to 208 million people, and from there, we expect to move quickly
across the bloc's trading countries in Latin America."
Uruguay
was the first country globally to establish cannabis legislation. Building upon
Khiron's previously announced acquisition of NettaGrowth International Inc. and
its wholly-owned subsidiary Dormul S.A., which obtained the first licence in
Uruguay to produce and export medical cannabis with THC for commercialization,
the Company is now initiating construction of the cultivation and processing
facility. Khiron has also begun pre-clinical studies in the country as part of
an initiative co-sponsored by the government of Uruguay using the Company's
strains. Identified as one of the most significant private-public medical
cannabis studies underway in Latin America, the research program has received
matching government funding for its medical innovation.
AMP German Cannabis
Group Inc.
(formerly "Chinook Tyee Industry Limited") (CSE: XCX) announced the commencement of trading of its common
shares on the Canadian Securities Exchange (CSE). The Company's common shares were delisted from
the TSX Venture Exchange at the close of market on September 3, 2019. The Company also announces that it has
updated investment policy to enhance shareholder value from investments in the
European medical cannabis industry.
Specifically,
the Company invests in businesses that supply the German market with European
Union – Good Manufacturing Practices ("EU-GMP") certified medical
cannabis. The Company's medical cannabis investment portfolio consists of AMP
Alternative Medical Products GmbH ("AMP Germany"), whose business is
to purchase EU-GMP certified medical cannabis from Canada for distribution in
Germany, and Alternative Medical Products Switzerland GmbH ("AMP
Switzerland"), whose business is to develop agreements to supply the German
market with cannabis cultivated from Switzerland.
Mr.
Alex Blodgett, CEO of AMP commented "AMP's current European investments in
the medical cannabis industry have been made to supply Germany with EU-GMP
cannabis which has been forecasted to be a $9-billion market by 2028. AMP is the only listed company that focuses
solely on supplying Germany with EU-GMP medical cannabis."
Dr.
Stefan Feuerstein, Managing Director of AMP Germany commented, "AMP
Germany plans to be a significant importer of EU-GMP cannabis to Germany from
Canada. Canada has become the second
largest supplier of EU-GMP cannabis to Germany since legalization of medical
cannabis in 2017."
Mr.
Claudio Morandi, Managing Director of AMP Switzerland commented, "It is
legal to cultivate cannabis with THC <1.0% in Switzerland, which has created
an emerging cannabis industry. AMP Switzerland is developing sources of
nutraceutical and EU-GMP cannabis for export to Germany once applicable laws
permit such transactions."
CannaOne
Technologies Inc. (CSE: CNNA) (OTC: CNONF) announced that it has entered into a Letter of
Intent to acquire 100% interest in Real Life Sciences Inc.
On
April 23rd, 2019, CannaOne Technologies announced a formal
partnership with Real Life Sciences to launch and operate the BWell CBD online
marketplace in the US. Under the terms of this agreement Real Life Sciences
acted as local managing partners for the BWell online marketplace providing
strategic management, financial and business development expertise. As the
managing partner of the BWell Marketplace, Real Life Sciences maintained a
75.1% ownership interest.
CannaOne
Technologies CEO, Mr. Riby-Williams, commented "Real Life Sciences'
expertise, vast network and strong relationships within the US has brought
substantial value to the BWell marketplace during the past months and has been
a key factor in the early launch for the business. BWell (www.thebwellmarket.com) is now capable of immediate sale and
delivery of 140 high quality CBD products at extremely competitive prices to
thousands of potential households in US.
We believe that this infrastructure and knowledge contributed by Real
Life Sciences to date provides substantial baseline support towards our Company
now acquiring a sole ownership stake in the BWell marketplace that will assist
to potentially provide long term substantial value to our shareholders."
Under
the terms of the LOI, following an extended period of Due Diligence, CannaOne
Technologies has agreed to purchase Real Life Sciences for $2,000,000 CAD, such
payment to be made in full through the issuance Company shares priced at a 20%
discount to the market as at the date of Closing. The Closing Date for this
transaction is set for October 25, 2019.
Village Farms
International, Inc. (TSX: VFF) (NASDAQ: VFF) today announced that its 50%-owned joint venture for
large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has
entered into a supply agreement with the British Columbia Liquor Distribution
Branch (BCLDB) to supply the BCLDB with Pure Sunfarms-branded cannabis products
for the recreational market in the Province of British Columbia.
Pure
Sunfarms will begin shipping packaged product to the BCLDB, as well as the
Ontario Cannabis Retail Corporation (the "OCRC", operating as the
Ontario Cannabis Store), with whom it entered into a supply agreement in February
2019, as soon as possible upon receipt of its license amendment permitting
sales and distribution directly to provincial/territorial wholesalers and
authorized private retailers in accordance with provincial/territorial
frameworks in Canada (sometimes referred to as a "packaging
license").
Combined,
Ontario and British Columbia comprise more than half of Canada's population,
with Ontario (Canada's most populated province) and British Columbia (Canada's
third most populated province) comprising more than 38% and more than 13% of
Canada's population, respectively). Pure Sunfarms also continues to advance
discussions with other provincial distributors for potential supply agreements.
"The
announcement of today's supply agreement with the BCLDB represents a major
milestone for Pure Sunfarms," said Mandesh Dosanjh, President and Chief
Executive Officer, Pure Sunfarms. "We are proudly B.C.-based, cultivating
cannabis to the highest standards by the most experienced growers in the
industry, and look forward to having Pure Sunfarms product available in our
home province."
"Pure
Sunfarms is already one of Canada's largest cannabis producers, with an
outstanding reputation for quality, consistency, safety and reliability,"
said Michael DeGiglio, CEO, Village Farms International. "This supply agreement for Canada's
third most populous province will significantly expand Pure Sunfarms' market
reach when it begins sales directly to provincial and territorial wholesalers,
taking the next step in establishing Pure Sunfarms as a premiere national brand
with Canadian cannabis consumers."
Aurora Cannabis
Inc. (NYSE: ACB) (TSX: ACB) announced today that on September 3, 2019, Aurora disposed
of its remaining 28,833,334 shares, representing 10.5% of the issued and
outstanding shares of The Green Organic Dutchman Holdings Ltd
("TGOD"), at a price of $3.00 per share for aggregate gross proceeds
of $86.5 million. The completion of the sale of TGOD shares represents an
approximate 50% internal rate of return for the Company. As a result of this
transaction, Aurora no longer holds any shares of TGOD, however does continue
to hold warrants to purchase 16,666,667 shares of TGOD.
"Aurora
has a broad portfolio of strategic investments that allow us to participate in
opportunities throughout the cannabis sector, while providing the company with
non-dilutive access to capital," said Terry Booth, CEO of Aurora. "We
evaluate our investment portfolio on a regular basis to make sure it continues
to align with our investment strategy and corporate priorities. When we
acquired Whistler Medical Marijuana Corporation – an iconic and premium organic
cannabis producer – our interest in TGOD became less important to our core
strategy. Our return on our TGOD investment is significant and will add
non-dilutive capital and further enhance our strategy to remain a dominant
force in the global cannabis industry."
Today’s podcast Sponsor:
Today’s
podcast was sponsored by CBDollars.
CBDollars is the first group of its kind designed to turn everyday people into
entrepreneurs of one the largest, most profitable industries that will ever
happen in this country. CBDollars will teach its members how to invest in the
cannabis industry through stocks, ETFs, and as Angel Investors; start a
wholesale store for a brick and mortar business; start an online store as a
dropshipper; private label your own
products from edibles to beauty & More. Join CBDOLLARS to lean more. https://www.facebook.com/groups/2117105128415627/
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement to
buy products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. Today’s podcast was sponsored by CBDollars.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment